Anthropic CEO Dario Amodei told prospective investors that artificial intelligence could help defeat some of humanity's deadliest diseases within a decade, a bold promise made in the roadshow video for the San Francisco company's initial public offering, which it released on Tuesday.
“You know, if today we look at things like cancer, Alzheimer's, heart disease, mental illness, these will be relics of the past in, I think, less than a decade,” Amodei said. “I think if we do this right, we can create an age of miracles where humanity is able to solve problems that have eluded us for millennia.” He tied the promise to safety, saying the company that gets the risks right will earn “the license to operate that society trusts.”
Amodei has made similar forecasts before. In his October 2024 essay “Machines of Loving Grace,” he argued that powerful AI could compress 50 to 100 years of biological progress into five to 10 years. But the new line, with a specific list of diseases and a deadline, comes as Anthropic courts Wall Street ahead of a Nasdaq listing set for Nov. 19.
Drug deals behind the pitch
The company says it is moving into medicine on several fronts. It is working with six biotech and pharmaceutical firms, including Bristol Myers Squibb, Generate Biomedicines and BigHat Biosciences, and has started its own drug discovery programs, including research on rare childhood forms of muscular dystrophy that it hopes could reach clinical trials by late 2028. In one project, scientists used its Claude model to redesign part of a CAR-T cancer therapy; Anthropic said the new version killed cancer cells faster in lab tests.

“Not likely,” says Eli Lilly's chief
The claim drew quick pushback from the drug industry and doctors. Eli Lilly Chairman and CEO Dave Ricks said: “I think that would be amazing and I think it's not likely. The map of biology is still largely a blank page and randomized human proof is the long pole in the tent,” pointing to the years that clinical trials take regardless of how fast new drug candidates are found.
Germany's former health minister Karl Lauterbach, a physician and epidemiologist, said curing cancer, Alzheimer's and mental illness “can definitely benefit from AI. But it cannot possibly happen in just 10 years.” Melinda Chu, a doctor and AI researcher at Saint Louis University, told Business Insider that “Anthropic has done nothing to suggest they themselves will contribute meaningfully to these goals.” Biotech executive Rami Elghandour said: “I've taken two companies public. These are insane things to say in an IPO pitch.”
Amodei himself has warned against such slogans. In August he wrote that “saying that AI will cure cancer is more a cliché than it is inspiring, and most people think it is deceptive,” adding that the best way to win over skeptics was to “actually cure cancer.”
Cover: Anthropic IPO roadshow video via Business Insider. Photo: Wikimedia Commons (CC BY 2.0)